Menu

• Ask a Health Expert about CONCOMITANT DISEASE PROGRESSION
• Post Your Side Effect related to CONCOMITANT DISEASE PROGRESSION
• CONCOMITANT DISEASE PROGRESSION and FDA Warnings
• CONCOMITANT DISEASE PROGRESSION in Patients Wiki
• Report CONCOMITANT DISEASE PROGRESSION in Drug Side Effect Survey

CONCOMITANT DISEASE PROGRESSION side effect

What is CONCOMITANT DISEASE PROGRESSION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Zoledronic Side Effects Report #5586367-X
Physician from UNITED STATES reported ZOLEDRONIC ACID problem on Jan 10, 2008. Female patient, 77 years of age, weighting 138.9 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, leg amputation, neuropathic arthropathy, osteomyelitis, prosthesis implantation, skin ulcer, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM GLUCONATE. Patient was hospitalized. Patient recovered.

Tysabri Side Effects Report #5605615-0
TYSABRI problem was reported by a Health Professional from on Jan 08, 2008. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, knee arthroplasty, osteoarthritis, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

Sirolimus Side Effects Report #5555047-9
Physician from UNITED STATES reported SIROLIMUS problem on Dec 03, 2007. Male patient, 51 years of age, was diagnosed with focal segmental glomerulosclerosis and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, focal segmental glomerulosclerosis, . SIROLIMUS dosage: unknown. Patient recovered.

Zoledronic Side Effects Report #5562730-8
ZOLEDRONIC ACID problem was reported by a Physician from BELGIUM on Dec 15, 2007. Female patient, 78 years of age, weighting 172.0 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, necrosis, osteomyelitis, toe amputation, toe operation, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM CARBONATE. Patient was hospitalized. Patient recovered.


Zoledronic Side Effects Report #5562732-1
Physician from BELGIUM reported ZOLEDRONIC ACID problem on Dec 15, 2007. Male patient, 68 years of age, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, gastroenteritis, hip arthroplasty, hip dysplasia, intestinal obstruction, osteoarthritis, osteonecrosis, pain in extremity, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, VITAMIN D, CALCIUM CARBONATE, STEOVIT D, BUSCOPAN. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5563357-4
ZOLEDRONIC ACID problem was reported by a Physician from CZECH REPUBLIC on Dec 17, 2007. Female patient, 78 years of age, weighting 154.3 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, coronary artery disease, pulmonary embolism, ventricular arrhythmia, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient died on 01/29/2006.

Zoledronic Side Effects Report #5566117-3
Physician from FINLAND reported ZOLEDRONIC ACID problem on Dec 19, 2007. Male patient, 51 years of age, weighting 216.1 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, diabetes mellitus, osteomyelitis, pyrexia, sepsis, toe amputation, wound, wound infection, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5568347-3
ZOLEDRONIC ACID problem was reported by a Physician from CANADA on Dec 20, 2007. Male patient, 70 years of age, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, hypertension, knee arthroplasty, osteoarthritis, post procedural complication, . ZOLEDRONIC ACID dosage: 5 MG Q 12 MONTHS. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5573288-1
Physician from FRANCE reported FEMARA problem on Dec 20, 2007. Female patient, 56 years of age, weighting 143.3 lb, was diagnosed with breast cancer and was treated with FEMARA. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, pemphigoid, pruritus genital, rash papular, skin lesion, . FEMARA dosage: unknown. Patient recovered.


Zoledronic Side Effects Report #5510976-7
ZOLEDRONIC ACID problem was reported by a Physician from ARGENTINA on Nov 08, 2007. Female patient, 86 years of age, weighting 143.3 lb, was diagnosed with osteoporotic fracture, tachyarrhythmia and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, cough, leukocytosis, neutrophilia, postoperative wound infection, pyrexia, staphylococcal infection, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with VITAMIN D, CALCIUM CARBONATE, ATLANSIL. Patient was hospitalized. Patient recovered.

Dacogen Side Effects Report #5463613-4
Physician from UNITED STATES reported DACOGEN problem on Sept 11, 2007. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, idiopathic pulmonary fibrosis, respiratory failure, . DACOGEN dosage: unknown. During the same period patient was treated with PULMICORT, CRESTOR. Patient died on 08/31/2007.

Lucentis Side Effects Report #5487243-3
LUCENTIS problem was reported by a Consumer or non-health professional from SWITZERLAND on Oct 05, 2007. Female patient was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, haematoma, . LUCENTIS dosage: 0.05 ML, UNK. During the same period patient was treated with AVASTIN. Patient was hospitalized and became disabled. Patient recovered.

Dacogen Side Effects Report #5463613-4
Physician from UNITED STATES reported DACOGEN problem on Sept 11, 2007. Male patient, 69 years of age, weighting 152.1 lb, was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, pulmonary fibrosis, respiratory failure, . DACOGEN dosage: unknown. During the same period patient was treated with PULMICORT, CRESTOR. Patient died on 08/31/2007.

Sandostatin Side Effects Report #5434307-6
SANDOSTATIN LAR problem was reported by a Physician from GERMANY on Aug 22, 2007. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, diabetic foot, peripheral vascular disorder, . SANDOSTATIN LAR dosage: unknown. During the same period patient was treated with LORZAAR, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.


Sandostatin Side Effects Report #5440767-7
Physician from GERMANY reported SANDOSTATIN LAR problem on Aug 22, 2007. Male patient, 73 years of age, weighting 216.1 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, coronary angioplasty, silent myocardial infarction, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.

Scopolamine Side Effects Report #5776475-2
SCOPOLAMINE problem was reported by a Pharmacist from IRELAND on June 05, 2008. Male patient, 74 years of age, was treated with SCOPOLAMINE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . SCOPOLAMINE dosage: unknown. Patient recovered.

Zoledronic Side Effects Report #5780278-2
Physician from UNITED KINGDOM reported ZOLEDRONIC ACID problem on June 20, 2008. Male patient was diagnosed with osteitis deformans and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, knee arthroplasty, osteoarthritis, . ZOLEDRONIC ACID dosage: 5MG. Patient was hospitalized. Patient recovered.

Ultravist Side Effects Report #5725107-8
ULTRAVIST problem was reported by a Health Professional from UNITED STATES on Apr 18, 2008. Female patient, 68 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, injection site extravasation, . ULTRAVIST dosage: unknown. Patient died on 04/01/2008.

Letrozole Side Effects Report #5710685-5
Physician from ITALY reported LETROZOLE problem on Apr 08, 2008. Female patient, 77 years of age, weighting 187.4 lb, was diagnosed with breast cancer and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, eye oedema, visual acuity reduced, . LETROZOLE dosage: 2.5 MG, QD. Patient recovered.


Letrozole Side Effects Report #5710687-9
LETROZOLE problem was reported by a Physician from ITALY on Apr 08, 2008. Female patient, 77 years of age, weighting 187.4 lb, was diagnosed with breast cancer and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, eye oedema, visual acuity reduced, . LETROZOLE dosage: 2.5 MG, QD. Patient recovered.

Ultravist Side Effects Report #5723500-0
Health Professional from UNITED STATES reported ULTRAVIST problem on Apr 18, 2008. Female patient, 68 years of age, was diagnosed with computerised tomogram and was treated with ULTRAVIST. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, injection site extravasation, . ULTRAVIST dosage: unknown. Patient died on 04/01/2008.

Velcade Side Effects Report #5346825-X
VELCADE problem was reported by a Physician from AUSTRALIA on May 22, 2007. Male patient, 46 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, fluid overload, leukaemia plasmacytic, plasmacytoma, renal failure, respiratory failure, . VELCADE dosage: unknown. Patient died on 01/17/2007.

Novoseven Side Effects Report #5313370-7
Health Professional from UNITED STATES reported NOVOSEVEN problem on Apr 24, 2007. Male patient, weighting 191.8 lb, was diagnosed with traumatic brain injury, subdural haematoma, subarachnoid haemorrhage, head injury and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . NOVOSEVEN dosage: unknown. Patient died on 08/26/2006.

Sirolimus Side Effects Report #5321152-5
SIROLIMUS problem was reported by a Physician from GERMANY on May 02, 2007. Male patient, 60 years of age, weighting 178.6 lb, was diagnosed with prophylaxis against transplant rejection, hypercholesterolaemia, hypertension, pain management and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, osteoarthritis, osteonecrosis, . SIROLIMUS dosage: 6 MG. During the same period patient was treated with FLUVASTATIN, BISOPROLOL FUMARATE, AMLODIPINE, PANTOPRAZOLE, METAMIZOLE. Patient was hospitalized. Patient recovered.

Novoseven Side Effects Report #5284201-9
Pharmacist from UNITED STATES reported NOVOSEVEN problem on Mar 21, 2007. Female patient, 92 years of age, weighting 200.6 lb, was diagnosed with traumatic haemorrhage, road traffic accident, ill-defined disorder, pulmonary embolism, atrial fibrillation and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . NOVOSEVEN dosage: unknown. During the same period patient was treated with CRYOPRECIPITATES, FIBRINOGEN, RED BLOOD CELLS, FRESH FROZEN PLASMA, PLATELETS, COUMADIN. Patient died on 11/02/2006.

Novoseven Side Effects Report #5305415-5
NOVOSEVEN problem was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient was diagnosed with traumatic haemorrhage and was treated with NOVOSEVEN. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, . NOVOSEVEN dosage: unknown. Patient died.

Sandostatin Side Effects Report #5276891-1
Physician from GERMANY reported SANDOSTATIN LAR problem on Mar 16, 2007. Male patient, 73 years of age, weighting 216.1 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, coronary angioplasty, silent myocardial infarction, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5276901-1
SANDOSTATIN LAR problem was reported by a Physician from GERMANY on Mar 16, 2007. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with diabetic retinopathy and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, diabetic foot, . SANDOSTATIN LAR dosage: unknown. During the same period patient was treated with LORZAAR, PENTOXIFYLLINE. Patient was hospitalized. Patient recovered.

Depocyt Side Effects Report #5650248-3
Physician from FRANCE reported DEPOCYT problem on Feb 18, 2008. Female patient, 65 years of age, was diagnosed with central nervous system lymphoma and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, concomitant disease progression, . DEPOCYT dosage: 50 MG, X4;. During the same period patient was treated with MABTHERA, CHLORAMINOPHEN, CORTICOSTEROID, TAHOR, AMILORIDE HYDROCHLORIDE, ALPRESS, MODOPAR. Patient was hospitalized. Patient recovered.

Entacapone Side Effects Report #5670521-2
ENTACAPONE problem was reported by a Physician from JAPAN on Mar 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, insomnia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON. Patient was hospitalized. Patient died on 09/29/2007.

Velcade Side Effects Report #5641581-X
Physician from JAPAN reported VELCADE problem on Feb 14, 2008. Male patient, 66 years of age, weighting 147.7 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, concomitant disease progression, enterocolitis, lymphocyte count decreased, neutrophil count decreased, oral herpes, pneumonia, protein total decreased, . VELCADE dosage: 2.00 MG, INTRAVENOUS; 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON, LEVOFLOXACIN, BAKTAR, LAXOBERON, SENNOSIDE A, PANTOSIN, PLATELETS. Patient recovered.

Zoledronic Side Effects Report #5556890-2
ZOLEDRONIC ACID problem was reported by a Physician from ARGENTINA on Dec 14, 2007. Female patient, 56 years of age, weighting 179.7 lb, was diagnosed with osteoporotic fracture, type 2 diabetes mellitus, hypothyroidism and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: amputation, concomitant disease progression, diabetes mellitus, enterococcal infection, morganella infection, osteomyelitis, skin ulcer, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D, GLYBURIDE, LEVOTIROXINA. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5568333-3
Physician from CANADA reported ZOLEDRONIC ACID problem on Dec 20, 2007. Female patient, 77 years of age, weighting 144.4 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, concomitant disease progression, dyspnoea, fall, pneumonia, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, VITAMIN D, CELEXA, LORAZEPAM. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5568362-X
ZOLEDRONIC ACID problem was reported by a Physician from SWITZERLAND on Dec 20, 2007. Female patient, 68 years of age, weighting 103.6 lb, was diagnosed with osteoporotic fracture and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: arthralgia, concomitant disease progression, fall, femoral neck fracture, femur fracture, hip arthroplasty, joint dislocation, osteonecrosis, . ZOLEDRONIC ACID dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM CARBONATE, VITAMIN D. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5573069-9
Physician from UNITED STATES reported ZOLEDRONIC ACID problem on Dec 18, 2007. Female patient, 67 years of age, weighting 200.6 lb, was diagnosed with breast cancer, osteoporosis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: bone density decreased, concomitant disease progression, fall, open reduction of fracture, radius fracture, ulna fracture, upper limb fracture, . ZOLEDRONIC ACID dosage: 4MG EVERY 6 MONTHS. During the same period patient was treated with CALCIUM, VITAMIN D, FEMARA. Patient was hospitalized. Patient recovered.

Lotrel Side Effects Report #5573697-0
LOTREL problem was reported by a Health Professional from UNITED STATES on Dec 18, 2007. Male patient, 69 years of age, weighting 169.3 lb, was diagnosed with hypertension, osteoarthritis, benign prostatic hyperplasia, diabetes mellitus and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: angioedema, concomitant disease progression, food allergy, swollen tongue, . LOTREL dosage: unknown. During the same period patient was treated with DITROPAN, NABUMETONE, PROSCAR, ASPIRIN, GLIPIZIDE. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5474355-3
Physician from JAPAN reported GLEEVEC problem on Sept 28, 2007. Female patient, 69 years of age, weighting 81.57 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: completed suicide, concomitant disease progression, depression, insomnia, stress, . GLEEVEC dosage: 300 MG, QD. During the same period patient was treated with VITAMEDIN S, GASMOTIN, DAIOU, KAMAG, FERROMIA, CATLEP, TOLEDOMIN. Patient died on 03/29/2006.

Gleevec Side Effects Report #5474459-5
GLEEVEC problem was reported by a Physician from JAPAN on Sept 28, 2007. Female patient, 69 years of age, weighting 81.57 lb, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: completed suicide, concomitant disease progression, depression, insomnia, stress, . GLEEVEC dosage: 300 MG, QD. During the same period patient was treated with VITAMEDIN S, GASMOTIN, DAIOU, KAMAG, FERROMIA, CATLEP, TOLEDOMIN. Patient died on 03/29/2006.

Entacapone Side Effects Report #5488311-2
Physician from JAPAN reported ENTACAPONE problem on Sept 19, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation, haemorrhoids and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.

Entacapone Side Effects Report #5501531-3
ENTACAPONE problem was reported by a Physician from JAPAN on Oct 23, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease, gastric ulcer, dyspepsia, constipation, haemorrhoids and was treated with ENTACAPONE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention, . ENTACAPONE dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.

Neoral Side Effects Report #5441338-9
Consumer or non-health professional from JAPAN reported NEORAL problem on Aug 27, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, pancreatitis, psychotic disorder, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.

Neoral Side Effects Report #5441339-0
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Aug 27, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, pancreatitis, psychotic disorder, . NEORAL dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.

Cyclosporine Side Effects Report #5413661-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Aug 09, 2007. Female patient, 61 years of age, was diagnosed with dermatomyositis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: candidiasis, concomitant disease progression, interstitial lung disease, psychotic disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, SIVELESTAT, STEROIDS NOS. Patient died.

Lotrel Side Effects Report #5375889-2
LOTREL problem was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 68 years of age, weighting 171.3 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, concomitant disease progression, diabetic nephropathy, dyspnoea, dyspnoea exertional, fluid overload, oedema, orthopnoea, proteinuria, . LOTREL dosage: unknown. During the same period patient was treated with LABETALOL, LASIX. Patient was hospitalized. Patient recovered.

Lotrel Side Effects Report #5375889-2
Physician from UNITED STATES reported LOTREL problem on June 21, 2007. Female patient, 68 years of age, weighting 171.3 lb, was diagnosed with hypertension and was treated with LOTREL. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, concomitant disease progression, diabetic nephropathy, dyspnoea, dyspnoea exertional, fluid overload, oedema, orthopnoea, proteinuria, . LOTREL dosage: unknown. During the same period patient was treated with LABETALOL, LASIX. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5779849-9
ZOLEDRONIC ACID problem was reported by a Physician from AUSTRALIA on June 20, 2008. Male patient, weighting 170.2 lb, was diagnosed with osteitis deformans, hypercholesterolaemia, gout and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, concomitant disease progression, dyspnoea, . ZOLEDRONIC ACID dosage: 5MG. During the same period patient was treated with ZOLEDRONIC ACID, PRAVACHOL, PROGESTIN, WARFARIN. Patient was hospitalized. Patient recovered.

Aclasta Side Effects Report #5793806-8
Physician from AUSTRALIA reported ACLASTA problem on June 26, 2008. Male patient, weighting 157.4 lb, was diagnosed with osteoporosis and was treated with ACLASTA. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, concomitant disease progression, dyspnoea, intervertebral discitis, osteomyelitis, pulmonary oedema, staphylococcal sepsis, . ACLASTA dosage: 5MG. During the same period patient was treated with AMIODARONE, PREDNISONE, BACTRIM. Patient was hospitalized. Patient recovered.

Tegaserod Side Effects Report #5731497-2
TEGASEROD problem was reported by a Physician from UNITED KINGDOM on May 06, 2008. Female patient, 52 years of age, weighting 147.7 lb, was diagnosed with irritable bowel syndrome and was treated with TEGASEROD. After drug was administered, patient experienced the following problems/side effects: colposuspension, concomitant disease progression, stress urinary incontinence, . TEGASEROD dosage: 2 MG, BID. Patient was hospitalized. Patient recovered.

Tegaserod Side Effects Report #5743579-X
Physician from UNITED KINGDOM reported TEGASEROD problem on May 15, 2008. Female patient, 52 years of age, weighting 147.7 lb, was diagnosed with irritable bowel syndrome and was treated with TEGASEROD. After drug was administered, patient experienced the following problems/side effects: colposuspension, concomitant disease progression, stress urinary incontinence, . TEGASEROD dosage: 2 MG, BID. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5715013-7
ZOLEDRONIC ACID problem was reported by a Physician from GERMANY on Apr 11, 2008. Male patient, 57 years of age, was diagnosed with osteoporosis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, concomitant disease progression, nausea, pancreatitis, vomiting, . ZOLEDRONIC ACID dosage: 5MG. During the same period patient was treated with CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.

Zoledronic Side Effects Report #5717259-0
Physician from GERMANY reported ZOLEDRONIC ACID problem on Apr 23, 2008. Male patient, 57 years of age, was diagnosed with osteoporosis and was treated with ZOLEDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: abdominal pain, concomitant disease progression, nausea, pancreatitis, vomiting, . ZOLEDRONIC ACID dosage: 5MG. During the same period patient was treated with CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.